A Novel Therapeutic Target for Pediatric Pneumonia: Sestrin2

Hatice Uygun1, Zeynep Nur Çiçek2, Kenan Ercan3

  • 1Department of Pediatric Infectious Disease, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey.

PubMed

Insights

Pediatric pneumonia patients show lower Sestrin2 (SESN2) levels, linked to increased oxidative stress. Boosting SESN2 may reduce complications and serve as a biomarker for childhood pneumonia.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Molecular Biology

Background:

  • Pneumonia complications' mechanisms remain unclear.
  • Sestrin2 (SESN2), an antioxidant protein, is implicated in various diseases.
  • The role of SESN2 in pediatric pneumonia requires investigation.

Purpose of the Study:

  • To investigate the relationship between Sestrin2 expression and pneumonia in hospitalized children.
  • To explore the correlation between Sestrin2, oxidative stress, and age in pediatric pneumonia.

Main Methods:

  • Compared Sestrin2 levels and reactive oxygen species (ROS) in 39 pediatric pneumonia patients and 37 healthy controls.
  • Analyzed correlations between Sestrin2, ROS, and patient age.

Main Results:

  • Pediatric pneumonia patients exhibited significantly lower SESN2 levels compared to controls (p=0.039).
  • A strong positive correlation was found between SESN2 and ROS (r=0.743, p=0.001).
  • A moderate negative correlation was observed between SESN2 and age (r=-0.467, p=0.003).

Conclusions:

  • Decreased SESN2 levels may contribute to pediatric pneumonia manifestations.
  • Increasing SESN2 levels could mitigate pneumonia-related complications by reducing oxidative stress.
  • SESN2 shows potential as a clinical biomarker and prognostic factor for pediatric pneumonia.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
710
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
479
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179